Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Research Across America
907
mi
from 43215
Dallas, TX
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Research Across America
907
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Research Across America
1008
mi
from 43215
Katy, TX
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Research Across America
1008
mi
from 43215
Katy, TX
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Advanced Clinical Research, Inc.
1519
mi
from 43215
West Jordan, UT
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Advanced Clinical Research, Inc.
1519
mi
from 43215
West Jordan, UT
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Clinical Research Partners, LLC
333
mi
from 43215
Henrico, VA
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Clinical Research Partners, LLC
333
mi
from 43215
Henrico, VA
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
Translational Research Group, INC., d/b/a Providence Clinical Research
1976
mi
from 43215
Burbank, CA
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
Translational Research Group, INC., d/b/a Providence Clinical Research
1976
mi
from 43215
Burbank, CA
Click here to add this to my saved trials
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  12/31/1969
St Louis Center For Clinical Research
406
mi
from 43215
Saint Louis, MO
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
Study SP304-20210: A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Repeat-Dose, Oral, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 12/31/1969
St Louis Center For Clinical Research
406
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Endoscopic Mucosal Resection for the Diagnosis of a-Ganglionosis, a Controlled Prospective Trial (EDGE Trial)
Endoscopic Mucosal Resection for the Diagnosis of a-Ganglionosis, a Controlled Prospective Trial (EDGE Trial)
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Endoscopic Mucosal Resection for the Diagnosis of a-Ganglionosis, a Controlled Prospective Trial (EDGE Trial)
Endoscopic Mucosal Resection for the Diagnosis of a-Ganglionosis, a Controlled Prospective Trial (EDGE Trial)
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Cahaba Research
492
mi
from 43215
Birmingham, AL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Cahaba Research
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Digestive Health Specialists of the Southeast
619
mi
from 43215
Dothan, AL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Digestive Health Specialists of the Southeast
619
mi
from 43215
Dothan, AL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Arrowhead Family Health Center PC dba Arrowhead Health Centers
mi
from 43215
Glendale, AZ
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Arrowhead Family Health Center PC dba Arrowhead Health Centers
mi
from 43215
Glendale, AZ
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Advanced Research Associates
1662
mi
from 43215
Glendale, AZ
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Advanced Research Associates
1662
mi
from 43215
Glendale, AZ
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Elite Clinical Trials, LLC
1655
mi
from 43215
Phoenix, AZ
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Elite Clinical Trials, LLC
1655
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Adobe Clinical Research, LLC
1636
mi
from 43215
Tucson, AZ
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Adobe Clinical Research, LLC
1636
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Genova Clinical Research
1640
mi
from 43215
Tucson, AZ
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Genova Clinical Research
1640
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Lynn Institute of the Ozarks
624
mi
from 43215
Little Rock, AR
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Lynn Institute of the Ozarks
624
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Anaheim Clinical Trials, LLC
1960
mi
from 43215
Anaheim, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Anaheim Clinical Trials, LLC
1960
mi
from 43215
Anaheim, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Advanced Rx Clinical Research
1968
mi
from 43215
Artesia, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Advanced Rx Clinical Research
1968
mi
from 43215
Artesia, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
GW Research Inc,
1949
mi
from 43215
Chula Vista, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
GW Research Inc,
1949
mi
from 43215
Chula Vista, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Sc Clinical Research, Inc.
1963
mi
from 43215
Garden Grove, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Sc Clinical Research, Inc.
1963
mi
from 43215
Garden Grove, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Community Clinical Trials
1959
mi
from 43215
Orange, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Community Clinical Trials
1959
mi
from 43215
Orange, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Healthcare Partners Medical Group
1965
mi
from 43215
Pasadena, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Healthcare Partners Medical Group
1965
mi
from 43215
Pasadena, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Medical Center for clinical research
1948
mi
from 43215
San Diego, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Medical Center for clinical research
1948
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Memorial Research Medical Clinic d/b/a Orange Country Research Center
1957
mi
from 43215
Tustin, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Memorial Research Medical Clinic d/b/a Orange Country Research Center
1957
mi
from 43215
Tustin, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Lynn Institute of the Rockies
1163
mi
from 43215
Colorado Springs, CO
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Lynn Institute of the Rockies
1163
mi
from 43215
Colorado Springs, CO
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Horizons Clinical Research Center, LLC
1159
mi
from 43215
Denver, CO
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Horizons Clinical Research Center, LLC
1159
mi
from 43215
Denver, CO
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Consultants for Clinical Research of South Florida
943
mi
from 43215
Boynton Beach, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Consultants for Clinical Research of South Florida
943
mi
from 43215
Boynton Beach, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Medical Research Unlimited
986
mi
from 43215
Hialeah, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Medical Research Unlimited
986
mi
from 43215
Hialeah, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Eastern Research, Inc.
989
mi
from 43215
Hialeah, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Eastern Research, Inc.
989
mi
from 43215
Hialeah, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Health Awareness
916
mi
from 43215
Jupiter, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Health Awareness
916
mi
from 43215
Jupiter, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Jupiter Research
915
mi
from 43215
Jupiter, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Jupiter Research
915
mi
from 43215
Jupiter, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
MNH Surgical Center
788
mi
from 43215
Maitland, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
MNH Surgical Center
788
mi
from 43215
Maitland, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Columbus Clinical Services, LLC
996
mi
from 43215
Miami, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Columbus Clinical Services, LLC
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
South Medical Research Group, Inc
996
mi
from 43215
Miami, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
South Medical Research Group, Inc
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Genoma Research Group, Inc.
995
mi
from 43215
Miami, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Genoma Research Group, Inc.
995
mi
from 43215
Miami, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
San Marcus Research Clinic
981
mi
from 43215
Miami, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
San Marcus Research Clinic
981
mi
from 43215
Miami, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Compass Research LLC
795
mi
from 43215
Orlando, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Compass Research LLC
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Urology Center of Florida
963
mi
from 43215
Pompano Beach, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Urology Center of Florida
963
mi
from 43215
Pompano Beach, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Accord Clinical Research
755
mi
from 43215
Port Orange, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Accord Clinical Research
755
mi
from 43215
Port Orange, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Meridien Research
830
mi
from 43215
Tampa, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Meridien Research
830
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Palm Beach Research Center
930
mi
from 43215
West Palm Beach, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Palm Beach Research Center
930
mi
from 43215
West Palm Beach, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Clinical Research of Central Florida
830
mi
from 43215
Winter Haven, FL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Clinical Research of Central Florida
830
mi
from 43215
Winter Haven, FL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Augusta University
451
mi
from 43215
Augusta, GA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Augusta University
451
mi
from 43215
Augusta, GA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Mount Vernon Clinical Research, LLC
423
mi
from 43215
Sandy Springs, GA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Mount Vernon Clinical Research, LLC
423
mi
from 43215
Sandy Springs, GA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
CTL Research
1723
mi
from 43215
Eagle, ID
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
CTL Research
1723
mi
from 43215
Eagle, ID
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Medex Healthcare Research, Inc.
274
mi
from 43215
Chicago, IL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Medex Healthcare Research, Inc.
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Rockford Gastroenterology Associates, Ltd.
349
mi
from 43215
Rockford, IL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Rockford Gastroenterology Associates, Ltd.
349
mi
from 43215
Rockford, IL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Heartland Research Associates, LLC
766
mi
from 43215
Augusta, KA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Heartland Research Associates, LLC
766
mi
from 43215
Augusta, KA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Research Integrity, Llc
266
mi
from 43215
Owensboro, KY
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Research Integrity, Llc
266
mi
from 43215
Owensboro, KY
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Delta Research Partners, LLC
699
mi
from 43215
Bastrop, LA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Delta Research Partners, LLC
699
mi
from 43215
Bastrop, LA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Gastroenterology Research of New Orleans
777
mi
from 43215
Hammond, LA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Gastroenterology Research of New Orleans
777
mi
from 43215
Hammond, LA
Click here to add this to my saved trials